Christina Armpilia

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Dr. Christina Armpilia is a leading expert in radiation oncology physics, with a primary focus on stereotactic ablative radiotherapy (SABR) for early-stage lung cancer. Her most cited work, "Robotic Stereotactic Ablative Radiotherapy for Patients with Early-Stage Lung Cancer: Results of an Interim Analysis," demonstrates her commitment to advancing non-invasive treatment alternatives for patients who are medically inoperable or refuse surgery. This research highlights the compelling potential of robotic SABR to deliver precise, high-dose radiation while minimizing damage to surrounding healthy tissue, offering a critical therapeutic option for vulnerable populations. With over two citations on this key paper, Dr. Armpilia's contributions are shaping clinical protocols and improving outcomes in thoracic oncology. Her work bridges the gap between cutting-edge technology and patient-centered care, establishing her as a notable figure in the field of radiation oncology. Through her rigorous analysis and dedication to evidence-based practice, Dr. Armpilia continues to influence how early-stage lung cancer is managed, providing hope and effective treatment for patients who lack surgical options.